Centiva Capital, LP Incyte Corp Put Options Transaction History

Centiva Capital, LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $172,068 - $215,436	-2,600 Reduced 96.3%	100 $7,000
Q2 2022 Aug 17, 2022	BUY	$66.18 - $83.18 $178,686 - $224,586	2,700 New	2,700 $206,000
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $875,324 - $1.29 Million	-11,800 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$63.18 - $85.97 $745,524 - $1.01 Million	11,800 New	11,800 $865,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.